Logo image of RNY.DE

(RNY.DE) Stock Fundamental Analysis

FRA:RNY - Deutsche Boerse Ag - CA98462Y1007 - Common Stock - Currency: EUR

5.391  -0.05 (-0.88%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to RNY. RNY was compared to 38 industry peers in the Metals & Mining industry. While RNY is still in line with the averages on profitability rating, there are concerns on its financial health. RNY has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year RNY was profitable.
In the past year RNY had a positive cash flow from operations.
In multiple years RNY reported negative net income over the last 5 years.
In the past 5 years RNY always reported a positive cash flow from operatings.
RNY.DE Yearly Net Income VS EBIT VS OCF VS FCFRNY.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 500M -500M -1B -1.5B -2B

1.2 Ratios

RNY has negative profitability rations, so we won't be analyzing them here.
Looking at the Return On Invested Capital, with a value of 3.82%, RNY is doing worse than 60.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for RNY is below the industry average of 6.60%.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 3.82%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.6%
ROIC(5y)N/A
RNY.DE Yearly ROA, ROE, ROICRNY.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -10 -20 -30 -40

1.3 Margins

The Operating Margin of RNY (17.93%) is better than 72.50% of its industry peers.
RNY's Operating Margin has improved in the last couple of years.
The Gross Margin of RNY (56.94%) is better than 92.50% of its industry peers.
RNY's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 17.93%
PM (TTM) N/A
GM 56.94%
OM growth 3Y5.08%
OM growth 5Y11.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.44%
GM growth 5Y6.17%
RNY.DE Yearly Profit, Operating, Gross MarginsRNY.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 50 -50 -100

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RNY is destroying value.
The number of shares outstanding for RNY remains at a similar level compared to 1 year ago.
The debt/assets ratio for RNY is higher compared to a year ago.
RNY.DE Yearly Shares OutstandingRNY.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M
RNY.DE Yearly Total Debt VS Total AssetsRNY.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2B 4B 6B 8B

2.2 Solvency

RNY has an Altman-Z score of 0.60. This is a bad value and indicates that RNY is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of RNY (0.60) is worse than 70.00% of its industry peers.
RNY has a debt to FCF ratio of 36.55. This is a negative value and a sign of low solvency as RNY would need 36.55 years to pay back of all of its debts.
With a Debt to FCF ratio value of 36.55, RNY perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
A Debt/Equity ratio of 0.25 indicates that RNY is not too dependend on debt financing.
RNY's Debt to Equity ratio of 0.25 is in line compared to the rest of the industry. RNY outperforms 52.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 36.55
Altman-Z 0.6
ROIC/WACC0.37
WACC10.34%
RNY.DE Yearly LT Debt VS Equity VS FCFRNY.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 1B 2B 3B 4B

2.3 Liquidity

RNY has a Current Ratio of 1.44. This is a normal value and indicates that RNY is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.44, RNY is not doing good in the industry: 72.50% of the companies in the same industry are doing better.
A Quick Ratio of 1.00 indicates that RNY should not have too much problems paying its short term obligations.
RNY has a Quick ratio (1.00) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1
RNY.DE Yearly Current Assets VS Current LiabilitesRNY.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M

2

3. Growth

3.1 Past

The earnings per share for RNY have decreased by -3.23% in the last year.
RNY shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 37.97% yearly.
The Revenue has decreased by -0.45% in the past year.
Measured over the past years, RNY shows a small growth in Revenue. The Revenue has been growing by 0.04% on average per year.
EPS 1Y (TTM)-3.23%
EPS 3Y44.23%
EPS 5Y37.97%
EPS Q2Q%-30%
Revenue 1Y (TTM)-0.45%
Revenue growth 3Y3.88%
Revenue growth 5Y0.04%
Sales Q2Q%-9.23%

3.2 Future

RNY is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -44.78% yearly.
The Revenue is expected to decrease by -3.15% on average over the next years.
EPS Next Y-9.36%
EPS Next 2Y-5.84%
EPS Next 3Y-44.78%
EPS Next 5YN/A
Revenue Next Year-0.27%
Revenue Next 2Y-0.71%
Revenue Next 3Y-3.15%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
RNY.DE Yearly Revenue VS EstimatesRNY.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
RNY.DE Yearly EPS VS EstimatesRNY.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.1 0.2 0.3

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.97 indicates a rather expensive valuation of RNY.
Compared to the rest of the industry, the Price/Earnings ratio of RNY indicates a slightly more expensive valuation: RNY is more expensive than 60.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.82, RNY is valued a bit cheaper.
With a Price/Forward Earnings ratio of 21.64, RNY is valued on the expensive side.
RNY's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, RNY is valued at the same level.
Industry RankSector Rank
PE 19.97
Fwd PE 21.64
RNY.DE Price Earnings VS Forward Price EarningsRNY.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as RNY.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of RNY is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 243
EV/EBITDA 7.73
RNY.DE Per share dataRNY.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

A cheap valuation may be justified as RNY's earnings are expected to decrease with -44.78% in the coming years.
PEG (NY)N/A
PEG (5Y)0.53
EPS Next 2Y-5.84%
EPS Next 3Y-44.78%

1

5. Dividend

5.1 Amount

RNY has a Yearly Dividend Yield of 1.26%.
RNY's Dividend Yield is comparable with the industry average which is at 3.21.
With a Dividend Yield of 1.26, RNY pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 1.26%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
RNY.DE Yearly Dividends per shareRNY.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 0.05 0.1 0.15

5.3 Sustainability

The earnings of RNY are negative and hence is the payout ratio. RNY will probably not be able to sustain this dividend level.
DP-11.67%
EPS Next 2Y-5.84%
EPS Next 3Y-44.78%
RNY.DE Yearly Income VS Free CF VS DividendRNY.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 0 -500M -1B -1.5B -2B

FRA:RNY (3/31/2023, 7:00:00 PM)

5.391

-0.05 (-0.88%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.19B
Analysts73.33
Price Target5.98 (10.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.26%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP-11.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.14%
Min EPS beat(2)16.48%
Max EPS beat(2)21.8%
EPS beat(4)4
Avg EPS beat(4)24.88%
Min EPS beat(4)16.48%
Max EPS beat(4)36.78%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.48%
Min Revenue beat(2)-2.82%
Max Revenue beat(2)-2.13%
Revenue beat(4)1
Avg Revenue beat(4)-1.46%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)3.55%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)30.1%
PT rev (3m)38.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)15.63%
EPS NY rev (1m)0%
EPS NY rev (3m)18.6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.12%
Valuation
Industry RankSector Rank
PE 19.97
Fwd PE 21.64
P/S 3.13
P/FCF 243
P/OCF 10.72
P/B 1.73
P/tB 1.96
EV/EBITDA 7.73
EPS(TTM)0.27
EY5.01%
EPS(NY)0.25
Fwd EY4.62%
FCF(TTM)0.02
FCFY0.41%
OCF(TTM)0.5
OCFY9.33%
SpS1.72
BVpS3.12
TBVpS2.75
PEG (NY)N/A
PEG (5Y)0.53
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 3.82%
ROICexc 4.09%
ROICexgc 4.39%
OM 17.93%
PM (TTM) N/A
GM 56.94%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.6%
ROIC(5y)N/A
ROICexc(3y)4.33%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y15.46%
ROICexcg growth 5Y19.42%
ROICexc growth 3Y15.08%
ROICexc growth 5Y19.12%
OM growth 3Y5.08%
OM growth 5Y11.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.44%
GM growth 5Y6.17%
F-Score3
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 36.55
Debt/EBITDA 1.08
Cap/Depr 108.14%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1
Altman-Z 0.6
F-Score3
WACC10.34%
ROIC/WACC0.37
Cap/Depr(3y)87.77%
Cap/Depr(5y)87.12%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.23%
EPS 3Y44.23%
EPS 5Y37.97%
EPS Q2Q%-30%
EPS Next Y-9.36%
EPS Next 2Y-5.84%
EPS Next 3Y-44.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.45%
Revenue growth 3Y3.88%
Revenue growth 5Y0.04%
Sales Q2Q%-9.23%
Revenue Next Year-0.27%
Revenue Next 2Y-0.71%
Revenue Next 3Y-3.15%
Revenue Next 5YN/A
EBIT growth 1Y-37.38%
EBIT growth 3Y9.16%
EBIT growth 5Y11.36%
EBIT Next Year131.94%
EBIT Next 3Y19.93%
EBIT Next 5YN/A
FCF growth 1Y-93.49%
FCF growth 3Y-50.33%
FCF growth 5YN/A
OCF growth 1Y-28.86%
OCF growth 3Y0.4%
OCF growth 5Y2.03%